InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Clackson Timothy P, Directeur, Président et CEO. Officer active across 4 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 10 disclosures have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €39k. Activity tracked since 17 June 2021. The latest transaction was filed on 23 July 2025 (U). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Clackson Timothy P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
47,330 股@ US$0.36100.0% 占其流量Common StockSEC:0001415889-25-020238:0
15,777 股0Common StockSEC:0001415889-23-012907:0
2,500 股@ US$6.79827.0% 占其流量Common StockSEC:0001104659-22-118549:0
标准退出：2023年2月9日 (T+90)
23,590 股Common StockSEC:0000899243-22-033647:0
31,553 股0Common StockSEC:0001209191-22-038758:0
4,500 股0Common StockSEC:0000899243-22-021662:0
2,600 股@ US$9.762157.4% 占其流量Common StockSEC:0000899243-21-049429:0
标准退出：2022年3月21日 (T+90)
2,750 股0Common StockSEC:0000899243-21-025092:0
29,333 股Common StockSEC:0001127602-16-039317:0
14,667 股Common StockSEC:0001127602-16-039317:1
10 条申报中的 10 条
About Clackson Timothy P
CLACKSON TIMOTHY P is Director, President and CEO. He has 10 filings in total. In the recent sample of 10 filings, the reported buy volume is EUR 39181 and the reported sell volume is EUR 0, and the filings run from 2016-02-03 to 2025-07-24. His listed companies are Elevation Oncology, Inc., Forma Therapeutics Holdings, Inc., Theseus Pharmaceuticals, Inc. and ARIAD PHARMACEUTICALS INC.
